[{"data":1,"prerenderedAt":150},["ShallowReactive",2],{"drug-moxifloxacin-eye":3},{"id":4,"schemaVersion":5,"name":6,"category":9,"class":10,"brands":13,"synonyms":17,"formulations":21,"regimens":34,"contraindications":50,"warnings":60,"renal":61,"monitoring":62,"interactions":63,"review":64,"examples":67,"atc":73,"iran":75,"links":95,"populations":110,"usApproval":145},"moxifloxacin-eye",1,{"fa":7,"en":8},"قطره چشمی موکسی‌فلوکساسین","Moxifloxacin eye drops","sensory-organs",{"fa":11,"en":12},"فلوروکینولون چشمی","Ophthalmic fluoroquinolone",[14],{"name":15,"market":16},"Vigamox","US",[18,19,20],"vigamox","ویگاموکس","موکسی فلوکساسین چشمی",[22],{"id":23,"form":24,"route":25,"label":26,"concentration":27,"markets":29,"refs":30},"sol-05","eye-drops","ophthalmic","Moxifloxacin 0.5% eye drops",{"amount":5,"unit":28,"perUnit":28},"drop",[16],[31],{"source":32,"section":33},"fda-vigamox","3",[35],{"id":36,"disease":37,"label":38,"population":41,"type":42,"unit":28,"dose":43,"refs":45,"durationDays":48},"conj","bacterial-conjunctivitis",{"fa":39,"en":40},"ورم ملتحمه باکتریایی — یک قطره ۳ بار در روز، ۷ روز","Bacterial conjunctivitis — 1 drop three times daily, 7 days",{},"fixed",{"perDose":5,"dosesPerDay":44},3,[46],{"source":32,"section":47},"2",{"min":49,"max":49},7,[51],{"id":52,"severity":53,"text":54,"refs":57},"hyper","block",{"fa":55,"en":56},"حساسیت به موکسی‌فلوکساسین یا سایر کینولون‌ها.","Hypersensitivity to moxifloxacin or other quinolones.",[58],{"source":32,"section":59},"4",[],[],[],[],{"status":65,"reviewer":66,"date":66},"unverified",null,[68],{"regimen":36,"formulation":23,"input":69,"expect":72},{"ageYears":70,"weightKg":71},30,70,{"perDose":5,"dosesPerDay":44},[74],"S01AE07",{"status":76,"forms":77,"refs":90},"registered",[78,82,86],{"code":79,"en":80,"fa":81},"14266","MOXIFLOXACIN 0.5% 5ML OPH DROP","قطره چشمی موکسی‌فلوکساسین ۰٫۵ درصد ۵ میلی‌لیتر",{"code":83,"en":84,"fa":85},"08277","MOXIFLOXACIN HCL 400MG TAB","قرص موکسی‌فلوکساسین هیدروکلراید ۴۰۰ میلی‌گرم",{"code":87,"en":88,"fa":89},"52529","MOXIFLOXACIN SOLUTION, DROPS OPHTHALMIC 0.5 % 0.5 mL","قطره چشمی موکسی‌فلوکساسین ۰٫۵ درصد ۰٫۵ میلی‌لیتر",[91],{"source":92,"section":93,"url":94},"darooyab-generic","G-444\u002FMoxifloxacin","https:\u002F\u002Fwww.darooyab.ir\u002FG-444\u002FMoxifloxacin",[96,100,104,107],{"kind":97,"url":98,"label":99},"fda","https:\u002F\u002Fwww.accessdata.fda.gov\u002Fscripts\u002Fcder\u002Fdaf\u002Findex.cfm?event=overview.process&ApplNo=021598","NDA021598",{"kind":101,"url":102,"label":103},"dailymed","https:\u002F\u002Fdailymed.nlm.nih.gov\u002Fdailymed\u002FdrugInfo.cfm?setid=12053b08-7e66-c6f3-e063-6394a90a9cd9","FDA Vigamox",{"kind":105,"url":106,"label":74},"who-atc","https:\u002F\u002Fatcddd.fhi.no\u002Fatc_ddd_index\u002F?code=S01AE07",{"kind":108,"url":94,"label":109},"darooyab","Moxifloxacin",{"pregnancy":111,"lactation":120,"pediatric":128,"geriatric":136},{"level":112,"text":113,"quote":116,"refs":117},"caution",{"fa":114,"en":115},"برچسب خطر مشخصی برای بارداری ذکر نکرده یا داده کافی ندارد؛ فقط در صورت لزوم و با نظر پزشک.","Label states no clear risk or has limited data; use only if needed, under medical advice.","Risk Summary There are no adequate and well-controlled studies with VIGAMOX ® in pregnant women to inform any drug-associated risks.",[118],{"source":32,"section":119},"8.1",{"level":112,"text":121,"quote":124,"refs":125},{"fa":122,"en":123},"برچسب: در شیردهی با احتیاط؛ متن برچسب را ببینید.","Label: use with caution while breastfeeding; see the label text.","Risk Summary There is no data regarding the presence of VIGAMOX ® in human milk, the effects on the breastfed infants, or the effects on milk production\u002Fexcretion to inform risk of VIGAMOX ® to an infant during lactation.",[126],{"source":32,"section":127},"8.2",{"level":112,"text":129,"quote":132,"refs":133},{"fa":130,"en":131},"برچسب برای کودکان شرط، محدودیت سنی یا نکته دارد؛ جمله برچسب در زیر آمده است.","The label has conditions, age limits or notes for children; the label sentence is quoted below.","The safety and effectiveness of VIGAMOX have been established in all ages.",[134],{"source":32,"section":135},"8.4",{"level":137,"text":138,"quote":141,"refs":142},"ok",{"fa":139,"en":140},"برچسب: در سالمندان تفاوت یا تنظیم دوز خاصی ذکر نشده.","Label: no specific difference or dose adjustment stated for older adults.","No overall differences in safety and effectiveness have been observed between elderly and younger patients.",[143],{"source":32,"section":144},"8.5",{"kind":146,"refs":147,"id":99},"NDA",[148],{"source":32,"section":149},"SPL approval \u002F marketing category",1792115189634]